Skip to content

Dr. Van der Vorst E.

Active Private limited companyfounded 2010active for 16 yearsErasmuslaan 26, 1780 WemmelKBO/BCE: BE 0826.914.508

Lifetime

15 annual accounts with figures on one time axis
peak of €194,215 in 2018
€181,830▲ 17.3%
lowest -€113,980 in 2011
€72,650▲ 44.0%
peak of €474,890 in 2025
€474,890▲ 18.1%
€452,433▼ 18.1%
Board1 name since 2010
1 director
Documentsfilings and deeds
31-01-2026on the last day
2025micro format
Gross margin from €155,079 to €181,830Result from €50,466 to €72,650Equity from €402,239 to €474,890Debts from €552,741 to €452,433Cash from €104,229 to €66,460

Key points

from the 2025 annual accounts

Equity

€474,890 ▲ 18.1%

Dr. Van der Vorst E. has made a profit without a break since 2014.

Turnover

≈ €340,000 estimated

The micro format states no turnover.

Filings

15 annual accounts since 2011
deadline201520202025

The last five annual accounts were filed 0 to 7 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,817 companies had the same profile as Dr. Van der Vorst E. has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,817 companies, not a prediction for Dr. Van der Vorst E.. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 21-06-2010
  • all the sharesdeed of 22-11-2011
Board & ownership

Recent changes

reappointed as director Gazette deed
Amendment of the articles holds all the shares · General meeting of 24-10-2011 · Gazette deed
Registered office moved from Dessel to Wemmel The registered office moved from Kattenberg 28, 2480 Dessel to Erasmuslaan 26, 1780 Wemmel · Gazette deed
New establishment At the time the registered office was still in Dessel.
All 26 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Van der Vorst E. Wemmel €927,323 €181,830 51.2% -
Dr Eva Roofthooft Haacht €835,917 €192,135 74.8% -
DEBRUYNE FREDERIK Tremelo €825,818 €164,640 53.9% -
ORTHOMEDEX Ostend €917,358 €180,673 28.8% -
CABINET DERMATOLOGIE ODILE WAUTERS Chaudfontaine €889,700 €175,911 2.8% 1
DR. PATRICK DE HERDT Schilde €889,268 €194,306 86.3% -
DR. NATHALIE LUCIDARME Koksijde €962,496 €169,995 60.6% -

These companies have the same main activity as Dr. Van der Vorst E.: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €826,000 and €962,000, founded between 2008 and 2011.

Official details

Source: KBO
Status
Active since 24-06-2010Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment units
2.211.298.6071000 Brussels, since 24-06-2010
2.303.267.6711780 Wemmel, registered on 24-10-2010
Financial year end
30 June
Peppol
Reachable via Peppol
Company details

Annual accounts to 30-06-2025

€927,323▼ 2.9%
Filing
Filed on 31-01-2026, on the last day of the filing period
Financials

Insights on Dr. Van der Vorst E.

Dr. Van der Vorst E. files the micro format. That format states no turnover. The gross margin rose from €17,060 in 2011 to €181,830 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Van der Vorst E.

What is the company number of Dr. Van der Vorst E.?
The company number of Dr. Van der Vorst E. is 0826.914.508. The VAT number is the same number with BE in front: BE 0826.914.508.
Where is Dr. Van der Vorst E. based?
The registered office is at Erasmuslaan 26, 1780 Wemmel.Company details
What does Dr. Van der Vorst E. do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Van der Vorst E.?
Dr. Van der Vorst E. is a private limited company (BV).
When was Dr. Van der Vorst E. founded?
Dr. Van der Vorst E. was founded on 24-06-2010.
Is Dr. Van der Vorst E. still active?
Yes, Dr. Van der Vorst E. is an active enterprise in the KBO register.
What is the turnover of Dr. Van der Vorst E.?
The turnover in financial year 2025 is about €340,000. This figure is estimated from the gross margin of €181,830 and 40 comparable companies (NACE 86220). It probably lies between €290,000 and €450,000.Financials
Is Dr. Van der Vorst E. profitable?
In financial year 2025, Dr. Van der Vorst E. made a profit of €72,650.
Where can I find the annual accounts of Dr. Van der Vorst E.?
Dr. Van der Vorst E. filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Van der Vorst E. due?
Dr. Van der Vorst E. must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.